CAPTRUST FINANCIAL ADVISORS - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 155 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2021. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q2 2022$8,000
+100.0%
6,7500.0%0.00%
Q1 2022$4,000
-42.9%
6,7500.0%0.00%
Q4 2021$7,000
-50.0%
6,750
-13.6%
0.00%
Q3 2021$14,000
-22.2%
7,810
+15.7%
0.00%
Q2 2021$18,000
-33.3%
6,750
-10.7%
0.00%
Q1 2021$27,000
+145.5%
7,556
+183.0%
0.00%
Q3 2019$11,0002,6700.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q1 2021
NameSharesValueWeighting ↓
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 14,642,959$25,186,0003.76%
MSD Partners, L.P. 15,151,516$26,061,0002.11%
MSD Partners, L.P. 7,575,758$13,030,0001.05%
MAGNOLIA CAPITAL ADVISORS LLC 418,569$720,0000.61%
STEEL GROVE CAPITAL ADVISORS, LLC 1,080,000$1,858,0000.33%
EAM Investors, LLC 454,625$782,0000.17%
Allred Capital Management, LLC 158,000$271,0000.17%
Boxer Capital, LLC 1,500,000$2,580,0000.14%
GSA CAPITAL PARTNERS LLP 608,037$1,046,0000.14%
CHIRON CAPITAL MANAGEMENT, LLC 116,860$201,0000.14%
View complete list of ZIOPHARM ONCOLOGY INC shareholders